|
YARS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.218800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.844300E-02 |
| Normal-vs-Stage2 |
4.446200E-02 |
| Normal-vs-Stage3 |
5.702300E-03 |
| Normal-vs-Stage4 |
6.146000E-02 |
| Stage1-vs-Stage2 |
1.476410E-01 |
| Stage1-vs-Stage3 |
3.746400E-02 |
| Stage1-vs-Stage4 |
1.024190E-01 |
| Stage2-vs-Stage3 |
7.883000E-01 |
| Stage2-vs-Stage4 |
2.361400E-01 |
| Stage3-vs-Stage4 |
2.738800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.161400E-03 |
| Normal-vs-AfricanAmerican |
6.020400E-03 |
| Normal-vs-Asian |
3.685200E-01 |
| Caucasian-vs-AfricanAmerican |
2.014400E-01 |
| Caucasian-vs-Asian |
5.521200E-01 |
| AfricanAmerican-vs-Asian |
5.712000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.012100E-02 |
| Normal-vs-Female |
5.53399999999593E-05 |
| Male-vs-Female |
1.417540E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.814100E-02 |
| Normal-vs-Extreme_Weight |
8.005700E-02 |
| Normal-vs-Obese |
7.016100E-03 |
| Normal-vs-Extreme_Obese |
6.686200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.501030E-01 |
| Normal_Weight-vs-Obese |
7.673000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.737700E-02 |
| Extreme_Weight-vs-Obese |
1.110790E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.761200E-01 |
| Obese-vs-Extreme_Obese |
1.337580E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.393730E-02 |
| Normal-vs-Age(41-60Yrs) |
3.327700E-02 |
| Normal-vs-Age(61-80Yrs) |
3.618700E-03 |
| Normal-vs-Age(81-100Yrs) |
4.853000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.985800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.760300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.043900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.819600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.892640E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.194500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.401200E-01 |
| Normal-VS-Type2 PRCC |
8.827400E-04 |
| Normal-VS-KIRP CIMP |
3.234900E-04 |
| Normal-VS-Unclassified PRCC |
6.499900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.439810E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.560600E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.804300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.037430E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.966200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.786800E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.810000E-02 |
| Normal-vs-N1 |
4.524300E-03 |
| Normal-vs-N2 |
2.924200E-01 |
| N0-vs-N1 |
4.741900E-02 |
| N0-vs-N2 |
3.631000E-01 |
| N1-vs-N2 |
5.953400E-01 |
|
|
